OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 73 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,227 | +34.4% | 1,152 | -1.7% | 0.00% | – |
| Q2 2023 | $10,583 | +10378.2% | 1,172 | -96.0% | 0.00% | -100.0% |
| Q1 2023 | $101 | +320.8% | 29,150 | +197.7% | 0.00% | +200.0% |
| Q4 2022 | $24 | -99.9% | 9,792 | +32.7% | 0.00% | – |
| Q3 2022 | $20,000 | -39.4% | 7,378 | -9.2% | 0.00% | -100.0% |
| Q2 2022 | $33,000 | +32.0% | 8,126 | +36.4% | 0.00% | – |
| Q1 2022 | $25,000 | -60.9% | 5,956 | -13.3% | 0.00% | -100.0% |
| Q4 2021 | $64,000 | +611.1% | 6,871 | +1988.4% | 0.00% | – |
| Q3 2021 | $9,000 | -73.5% | 329 | -73.2% | 0.00% | -100.0% |
| Q2 2021 | $34,000 | -12.8% | 1,229 | +5.2% | 0.00% | 0.0% |
| Q1 2021 | $39,000 | +44.4% | 1,168 | +104.9% | 0.00% | 0.0% |
| Q4 2020 | $27,000 | – | 570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |